A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet.
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000014581
- Lead Sponsor
- Enomoto naika clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Dementia patients except Alzheimer's disease 2.Patients who have severe mental disorder 3.Patients who are pregnant or trying to get pregnant, or during breastfeeding 4.Patients with a history of the hypersensitivity for Memantine hydrochloride tablets 5.The case that a investigator judged to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of functionality
- Secondary Outcome Measures
Name Time Method Evaluation of safety